1998
DOI: 10.1038/sj.sc.3100566
|View full text |Cite
|
Sign up to set email alerts
|

Glucose intolerance and dyslipidaemias in persons with paraplegia and tetraplegia in South India

Abstract: Glucose intolerance and dyslipidaemias have been reported among paraplegics and tetraplegics. In this study we determined the lipid pro®les and the glucose tolerance in a group of 48 persons with spinal cord lesions who had been rehabilitated in our Department of Physical Medicine and Rehabilitation. This non-randomised, descriptive study was conducted as part of the annual medical follow-up of these individuals. Hypertension was observed in only 6% of the subjects. Fasting hyperglycemia was observed in 19% an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 9 publications
0
14
0
Order By: Relevance
“…26 Patients with SCI have also been shown to have increased prevalence of impaired glucose tolerance, insulin resistance and diabetes, owing to the aforementioned adverse changes in body composition and, potentially, unknown causes. 4,[7][8][9] Other previously reported CHD risk factors after SCI include decreased physical activity, psychosocial factors of depression and social isolation, 27 elevated plasma homocysteine, 28 and increased levels of C-reactive protein. 29,30 In addition, evidence suggests that persons with chronic SCI have a circulating heavy-chain IgG that is the cause of loss of high-affinity prostacyclin receptors in platelets, which results in the absence of prostaglandin-induced inhibition of platelet-stimulated thrombin generation; furthermore, this IgG fragment is heterophilic, binding the platelet insulin receptor and blocking platelet nitric oxide synthesis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…26 Patients with SCI have also been shown to have increased prevalence of impaired glucose tolerance, insulin resistance and diabetes, owing to the aforementioned adverse changes in body composition and, potentially, unknown causes. 4,[7][8][9] Other previously reported CHD risk factors after SCI include decreased physical activity, psychosocial factors of depression and social isolation, 27 elevated plasma homocysteine, 28 and increased levels of C-reactive protein. 29,30 In addition, evidence suggests that persons with chronic SCI have a circulating heavy-chain IgG that is the cause of loss of high-affinity prostacyclin receptors in platelets, which results in the absence of prostaglandin-induced inhibition of platelet-stimulated thrombin generation; furthermore, this IgG fragment is heterophilic, binding the platelet insulin receptor and blocking platelet nitric oxide synthesis.…”
Section: Discussionmentioning
confidence: 99%
“…4,[7][8][9] Additionally, these patients may not have symptoms despite significant CHD, partially owing to their reduced level of activity. 10 Thus, it is important to identify the presence of subclinical disease in these patients to initiate appropriate treatment for the primary prevention of CHD.…”
Section: Introductionmentioning
confidence: 99%
“…Impaired glucose tolerance, insulin resistance and diabetes occur more frequently in SCI versus able-bodied persons. 15,38,[41][42][43][44][45] Other potential CHD risk factors after SCI include decreased physical activity, psychosocial factors (depression, isolation), and elevated plasma homocysteine and C-reactive protein. 46 Increased fat mass has also been identified as an important risk factor in chronic SCI and weight management is recommended as a key CHD prevention strategy.…”
Section: Body Mass Index (Bmi) As a Marker Of Obesity In Chronic Scimentioning
confidence: 99%
“…Impaired glucose tolerance and diabetes mellitus occur more frequently in persons with SCI than in the able‐bodied population 75,76,83–86 . Peripheral resistance of insulin to mediate glucose uptake may be demonstrated in most individuals with SCI having a disorder in glucose tolerance.…”
Section: Carbohydrate Metabolism In Persons With Scimentioning
confidence: 99%